Risk factors for fracture among current, persistent users of bisphosphonates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk factors for fracture among current, persistent users of bisphosphonates

Published:2014-10-30 Issue:2 Volume:26 Page:713-725
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

LeBlanc E. S.,Rosales A. G.,Balasubramanian A.,O’Malley C. D.,Egbuna O.,Friess D.,Perrin N. A.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-014-2941-9.pdf

Reference33 articles.

1. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD001155

2. Bilezikian JP (2009) Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am J Med 122:S14–S21

3. Feldstein AC, Weycker D, Nichols GA, Oster G, Rosales G, Boardman DL, Perrin N (2009) Effectiveness of bisphosphonate therapy in a community setting. Bone 44:153–159

4. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, Agnusdei D, Iori N, Nuti R (2006) Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res 21:1565–1570

5. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (vert) study group. Osteoporos Int 11:83–91

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy and risk of fractures in older adults: A systematic review;Journal of Evidence-Based Medicine;2024-03

2. Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland;Archives of Osteoporosis;2021-04-17

3. Comparing the efficacies of bisphosphonates’ therapies for osteoporosis persistence and compliance: A Systematic Review;Current Molecular Medicine;2021-04-14

4. Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland;2020-10-07

5. Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review;BMJ Open;2019-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3